Results tagged “GILD” from MarketMinute.com Market Updates
Investors concerned about a stalled global economic recovery sent the markets down to a lower close with the Dow falling 57 points to 10,213. Nasdaq edged up a fraction to 2179.
On the upside
Mentor Graphics (Nasdaq: MENT) narrowed second quarter losses more than expected as revenue rose.
Mueller Water Products (NYSE: MWA) priced its offering of $225 million worth of senior notes.
Rumors that Akamai (Nasdaq: AKAM) may be the target of an acquisition lifted shares of the company for a second day.
On the downside
Second quarter earnings for Hibbett Sports (Nasdaq: HIBB) surged and the company lifted its full year outlook but the results fell short of expectations.
Sigmapharm applied for regulatory approval to produce a generic version of Gilead's (Nasdaq: GILD) hepatitis B treatment Hepsera.
GE Capital (NYSE: GE) will provide Blount International (NYSE: BLT) with a $425 million cash flow credit facility.
In the broad market, declining issues outpaced advancers by a margin of more than 3 to 2 on the NYSE while decliners barely edged out advancers by a slim margin on Nasdaq. The Russell 2000 which tracks small cap stocks eased a fraction to 610.
Upbeat retailer earnings reports lifted the markets to a modestly higher close with the Dow adding 9 points to 10,415. Nasdaq rose 6 points to 2215.
On the upside
ValueVision Media (Nasdaq: VVTV) narrowed second quarter losses as revenue rose.
Citigroup analyst Josh Levin suggested that homebuilders are likely to consolidate, lifting shares of Beazer Homes (NYSE: BZH) and Ryland Group (NYSE: RYL).
China Digital (NYSE: STV) reported higher second quarter earnings that beat expectations as revenue soared.
Dillard's (Nasdaq: ENDP) announced plans to buy back as much as $250 million worth of common shares.
On the downside
Gilead Sciences (Nasdaq: GILD) spent $350,000 in the second quarter to lobby the federal government.
Fiduciary/Claymore MLP Opportunity Fund (NYSE: FMO) priced its offering of nearly 4.3 million shares at $19.36 per share.
In the broad market, advancing issues outpaced decliners by a margin of more than 7 to 5 on the NYSE and by nearly 5 to 4 on Nasdaq. The Russell 2000 which tracks small cap stocks gained 4 points to 630.
It was a flat close for the markets with the Dow easing a point to 10,302 over concerns that Japan's slowing economic growth will spread to other countries. Nasdaq rose 8 points to 2181.
On the upside
Hauppauge Digital (Nasdaq: HAUP) swung to a third quarter profit as revenue rose and expenses fell.
Wedbush upgraded Calgon Carbon (NYSE: CCC) to an Outperform rating on Friday.
BPZ Resources (NYSE: BPZ) received an Extended Well Testing permit through November 30, 2010 for the CX11-17D well in the Corvina field in Block Z-1.
On the downside
Shares of Great Atlantic & Pacific Tea (NYSE: GAP) continued to fall after announcing the closure of 25 stores on Friday.
Flextronics International (NYSE: FLEX) announced a plan on Friday to repurchase up to $200 million in stock.
Deutsche Bank analyst Robyn Karnauskas initiated coverage of Gilead Sciences (Nasdaq: GILD) with a Buy rating and a price target of $42.
In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 3 on both the NYSE and on Nasdaq. The Russell 2000 which tracks small cap stocks gained 5 points to 615.
The markets advanced during the midday with the Dow climbing 63 points to 10,487 as new home sales rise more than expected. Nasdaq gained 16 points to 2285.
On the upside
Rumors circulated that Star Scientific (Nasdaq: CIGX) may be acquired.
Astrotech (Nasdaq: ASTC) won a $9.5 million contract to provide payload processing services to NASA.
Second quarter earnings rose for China Security and Surveillance Technology (NYSE: CSR) and the company forecast full year results ahead of estimates.
On the downside
Noah Education Holdings (NYSE: NED) blamed disruptions caused by a new channel realignment initiative for slashing its fourth quarter revenue guidance.
Gilead Sciences (Nasdaq: GILD) will raise capital through the offering of approximately $2.2 billion worth of senior convertible notes.
Shares of Rosetta Stone (NYSE: RST) continued falling after forecasting second quarter revenue below expectations last week.
In the broad market, advancing issues outpaced decliners by a margin of nearly 3 to 1 on the NYSE and by nearly 5 to 2 on Nasdaq. The Russell 2000 which tracks small cap stocks climbed 10 points to 660.
A greater than expected surge in new home sales boosted the markets during the midday with the Dow gaining 73 points to 10,116. Nasdaq climbed 25 points to 2236.
On the upside
The Food and Drug Administration will review MELA Sciences' (Nasdaq: MELA) pre-market application for its melanoma detection tool MelaFind.
Central Jersey Bancorp (Nasdaq: CJBK) and Kearny Financial (Nasdaq: KRNY) will merge in a deal valued at approximately $72.3 million.
J.P. Morgan Chase upgraded US Airways Group (NYSE: LCC).
On the downside
Investors locked in profits on Sprint (NYSE: S), whose shares surged recently.Morgan Joseph analyst Shiv Kapoor said that long term growth for Gilead (Nasdaq: GILD) is poor citing a number of drug patents that are set to expire in seven to eight years.
Psagot analyst Limor Gruber upgraded Teva Pharmaceutical (NYSE: TEVA) and raised her price target for the generic drug maker but the stock price fell.
In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 1 on the NYSE and by nearly 4 to 1 on Nasdaq. The Russell 2000 which tracks small cap stocks soared 12 points to 652.
Renewed fears that European debt problems will hinder the global economic recovery sent the markets into a tailspin with the Dow plummeting 376 points to 10,068. Nasdaq sank 94 points to 2204.
On the downside
In an antitrust suit against General Electric (NYSE: GE), Mitsubishi accused General Electric of making meritless patent infringement claims against the company and monopolizing the wind turbine market.
Wells Fargo (NYSE: WFC) introduced a new student loan program with no origination fees or early payment fees.
The Motley Fool investment community rated Wave Systems (Nasdaq: WAVX) a one star stock out of five stars.
FormFactor (Nasdaq: FORM) announced that chief executive Mario Ruscev and chief financial officer Jean Bernard Vernet both resigned effective immediately.
Gilead (Nasdaq: GILD) spent $480,000 in the first quarter to lobby the federal government.
Dell (Nasdaq: DELL) reported higher first quarter earnings as revenue rose but the stock price fell.
In the broad market, declining issues outpaced advancers by a margin of 10 to 1 on the NYSE and by more than 11 to 1 on Nasdaq. The Russell 2000 which tracks small cap stocks skidded 34 points to 640.
On the upside
Visa (NYSE: V) will acquire online payment processor CyberSource (Nasdaq: CYBS) for approximately $2 billion in cash.
Morgan Stanley (NYSE: MS) swung to a first quarter profit that beat analyst expectations by a wide margin as revenue surged.
KeyCorp (NYSE: KEY) narrowed first quarter losses.
On the downside
First quarter earnings for Gilead Sciences (Nasdaq: GILD) surged to top analyst estimates but the biopharmaceutical lowered its 2010 revenue outlook.
While first quarter earnings for Yahoo (Nasdaq: YHOO) nearly tripled, revenue fell short of expectations.
Synovus Financial (NYSE: SNV) widened first quarter losses due to rising loan loss provisions.
In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 3 on the NYSE while advancers barely edged out decliners by a slim margin on Nasdaq. The Russell 2000 which tracks small cap stocks added a point to 723.
On the upside
Thermo Fisher Scientific (NYSE: TMO) offered to acquire Millipore (NYSE: MIL) for approximately $6 billion.
Green Plains Renewable (Nasdaq: GPRE) reversed year ago losses to post a profit for the fourth quarter.
Shares of Huntsman (NYSE: HUN) continued to rise after reporting on Friday fourth quarter earnings that topped estimates.
On the downside
Unconfirmed reports surfaced that orders for Research In Motion's (Nasdaq: RIMM) Blackberry Storm were being cancelled or cut.
Morgan Joseph analyst Shiv Kapoor downgraded Gilead (Nasdaq: GILD) to a Sell rating saying that patents for five of the company's major drugs will expire at the end of the decade.
Goldman Sachs downgraded Graco (NYSE: GGG) to a rating of Sell due to concerns of a strengthening dollar.
In the broad market, advancing issues barely outpaced decliners by a slim margin on the NYSE and by more than 10 to 9 on Nasdaq. The Russell 2000 which tracks small cap stocks edged up a fraction to 632.
On the upside
A surge in new home construction lifted shares of Hovnanian Enterprises (NYSE: HOV) and Beazer Homes (NYSE: BZH).
Second quarter earnings for AAR (NYSE: AIR) rose to beat expectations as expenses slipped.
Shares of Mizuho Financial Group (NYSE: MFG) soared after the Basel Committee on Banking Supervision delayed the enforcement of stricter capital requirements.
On the downside
Gilead (Nasdaq: GILD) stock continued to fall after its high blood pressure medication failed a late stage clinical trial.
Fifth Third Bancorp (Nasdaq: FITB) originated and renewed fewer commercial and industrial loans in October compared with September.
Shares of CVS (NYSE: CVS) slipped after Walgreen (NYSE: WAG) announced that it will expand its swine flu vaccination program to 27 states and make the vaccine available to anyone within the age requirement.
In the broad market, advancing issues outpaced decliners by a margin of nearly 2 to 1 on the NYSE and by 7 to 5 on Nasdaq. The Russell 2000 which tracks small cap stocks rose 4 points to 611.
On the upside
Mad Money's Jim Cramer recommended Fluor (NYSE: FLR) citing the company's significant backlog.
Steak n Shake (NYSE: SNS) reversed year ago losses to post a profit for the fourth quarter as revenue rose.
TheStreet.com recommended that investors sell Dell (Nasdaq: DELL) but the stock price rose.
On the downside
Nasdaq notified Cyclacel Pharmaceuticals (Nasdaq: CYCC) that it was not in compliance with the $10 million market capital requirement for listing on the exchange.
Gilead Sciences' (Nasdaq: GILD) high blood pressure medication darusentan failed a late stage clinical trial.
The International Air Transport Association widened its expected losses for the airline industry sending shares of UAL (Nasdaq: UAUA) and Continental Airlines (NYSE: CAL) tumbling.
In the broad market, declining issues outpaced advancers by a margin of nearly 5 to 3 on both the NYSE and on Nasdaq. The Russell 2000 which tracks small cap stocks lost 3 points to 606.
On the upside
Gilead Sciences (Nasdaq: GILD) will pay approximately $1.4 billion to acquire CV Therapeutics (Nasdaq: CVTX).Although fourth quarter earnings for Men's Weahouse (NYSE: MW) plunged, the results were better than expected prompting analyst to upgrade the retailer.
Hanesbrands (NYSE: HBI) amended its credit agreement as a precaution to ensure that the company will be able to meet it debt requirements.
On the downside
YRC Worldwide (Nasdaq: YRCW) said that cost cutting measures should significantly improve second quarter results.
Second quarter earnings for Pall (NYSE: PLL) dropped to fall short of expectations as revenue tumbled amidst the economic slump.
Quiksilver (NYSE: ZQK) blamed a decline in sales and significant losses from discontinued operations for widening first quarter losses.
In the broad market, advancing issues outpaced decliners by a margin of more than 3 to 1 on the NYSE and by 5 to 2 on Nasdaq. The Russell 2000 which tracks small cap stocks leaped 11 points to 377.
A volatile day of trading ended with the markets surging in late afternoon trading with the Dow soaring 401 points to 8979 as crude oil prices retreated to a 14-month low and consumer prices held steady. Nasdaq jumped 89 points to 1718.
On the upside
Shares of United Air Lines parent UAL (Nasdaq: UAUA), US Airways (NYSE: LCC) and American Airlines parent AMR (NYSE: AMR) all rose after crude oil prices retreated to a 14-month low of $69.85 per barrel.
Gilead Sciences (Nasdaq: GILD) reported higher third quarter earnings as sales of its HIV treatment climbed.
Standard & Poor's comments that insurance pricing has improved lifted shares of Ambac Financial Group (NYSE: ABK) and MBIA (NYSE: MBI).
On the downside
Although Badger Meter (NYSE: BMI) reported higher third quarter revenue, earnings were flat compared with last year.
Winnebago Industries (NYSE: WGO) blamed the sluggish economy, high gas prices and tight credit markets for swinging to a fourth quarter loss. The recreational vehicle maker also suspended its dividend.
In the broad market, declining issues outpaced advancers by a margin of 9 to 2 on the NYSE and by more than 2 to 1 on Nasdaq. The Russell 2000 which tracks small cap stocks leaped 34 points to 537.
It was a mixed close for the markets as retreating oil prices tempered news of an unexpected jump in jobless claims. The Dow gained 33 points to 11,221 while Nasdaq eased 3 points to 2256.
On the upside
Second quarter earnings for Ulta Salon, Cosmetics & Fragrance (Nasdaq: ULTA) soared to top estimates as sales climbed.
Bank of America (NYSE: BAC), Citigroup (NYSE: C) and Wachovia (NYSE: WB) are among nine banks that have agreed to settle federal and state inquiries into auction rate securities sales by buying back more than $50 billion of securities.
Although Morgan Stanley analyst Nigel Dally downgraded American International Group (NYSE: AIG) over liquidity concerns, shares of the world's largest insurer rose.
On the downside
Although ABM (NYSE: ABM) posted higher third quarter earnings, the company lowered its full year outlook.
Brazil's rejected Gilead Sciences' (Nasdaq: GILD) patent request for its AIDS treatment Tenofovir saying that the drug lacked technological inventiveness.
Copper prices dropped to a seven month low to weigh down shares of Freeport-McMoRan Copper & Gold (NYSE: FCX).
In the broad market, advancing issues barely edged out decliners by a slim margin on the NYSE while decliners outpaced advancers by nearly 9 to 7 on Nasdaq. The Russell 2000 which tracks small cap stocks edged up a fraction to 719.
Despite sharply lower oil prices, the markets closed lower as manufacturing activity fell and construction spending dropped more than expected. The Dow lost 27 points to 11,517 while Nasdaq tumbled 18 points to 2349.
On the upside
Freddie Mac (NYSE: FRE) sold $1 billion in five-year debt though an auction and will sell $3 billion in two-year debt tomorrow.
Shares of Puerto Rico based bank Popular (Nasdaq: BPOP) continued to rise after announcing plans to sell $1.17 billion worth of U. S. mortgage assets to Goldman Sachs.
The Air Transport Association reported that airliners improved fuel efficiency while reducing harmful emissions in 2007. Shares of Northwest (NYSE: NWA), Delta (NYSE: DAL) and Continental Airlines (NYSE: CAL) soared.On the downside
Privately held Transcept Pharmaceuticals will acquire biopharmaceutical Novacea (Nasdaq: NOVC) in an all stock deal.
Shares of U. S. Steel (NYSE: X) tumbled after the Institute for Supply Management reported a drop in manufacturing activity in August while the Commerce Department reported a sharper than expected decline in construction spending.
Banc of America analyst William Ho downgraded Gilead Sciences (NYSE: GILD) as growth for the biotechnology company's HIV drugs slow.In the broad market, advancing issues outpaced decliners by a margin of nearly 9 to 8 on the NYSE while declining issues barely edged out advancer on Nasdaq. The Russell 2000 which tracks small cap stocks eased a point to 739.
On the upside
Citigroup (NYSE: C) posted a $2.5 billion loss, but the results were better than expected.
Toy maker Mattel (NYSE: MAT) reported higher revenues as earnings fell due to higher costs. Investors were generally pleased with the results which beat expectations.
Generic drug maker Barr Pharmaceuticals (NYSE: BRL) received a $7 billion cash and stock offer from Israeli drugmaker Teva Pharmaceutical (Nasdaq: TEVA).
On the downside
Google (Nasdaq: GOOG) posted higher revenues and earnings that showed the effects of a slowing economy. Investors hoping for recession-proof results promptly sold the stock.
Overstock.com (Nasdaq: OSTK) posted higher revenues due to the addition of half a million online customers, but investors focused on the continued losses.
Biotechnology company Gilead Science (Nasdaq: GILD) reported higher revenues and earnings on increased HIV drug sales. Analysts attributed much of the gains to a favorable currency exchange rate and downgraded the stock on valuation.
In the broad market, declining issues outpaced advancers by a
margin of 5 to 4 on the NYSE and by 4 to 3 on
Nasdaq. The Russell 2000 which tracks small cap stocks lost 3 points to 692.